AMTM Options Optimism Collides with a Dimming Growth Outlook
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Amentum Holdings enters the final stretch before its November 24 earnings report with a striking internal contradiction: options traders are more bullish than at almost any point in the past year, yet the Street has been steadily cutting price targets, short sellers have been adding exposure, and the company's own preliminary FY27 guidance rattled investors earlier this quarter.
The options signal is the most unusual data point this week. Call demand has surged relative to puts, pushing the put/call ratio to 0.40, well below its 20-day average of 0.43 and sitting 3.6 standard deviations below the mean. That makes it the most call-skewed reading of the past year, with the 52-week low at 0.20 and the high at 0.47. This is a sharp reversal from the cautious stance implied by the stock's prior months of underperformance. Whether this reflects fresh optimism after the 9.5% weekly rally or simply short-dated speculation ahead of the earnings date, it sits in notable tension with the broader picture from the lending and analyst side.
Short interest has been quietly building, which complicates the bullish options read. At 5.4% of the free float, with roughly 13.1 million shares short, the position has grown about 9.5% over the past week and close to 8.6% over the past month. That pace of accumulation is not alarming in isolation, but it does suggest some investors are actively fading the rally. Borrow costs remain very low at 0.47%, and availability is ample at 437%, meaning there is no squeeze pressure in the lending market to support a technical short-covering rally. The ORTEX short score has drifted up to 57.5 from around 54.4 two weeks ago, a moderate but notable move in the bearish direction. Positioning, in aggregate, looks split rather than unified: call buyers say one thing, short sellers say another, and the lending market is relaxed enough that neither side faces unusual friction.
The analyst community has moved in one direction only, and it is not up. RBC Capital trimmed its target to $25 from $26 this week, maintaining a Sector Perform rating. That follows a cluster of cuts from August, when JP Morgan, BTIG, and UBS all moved targets lower following the prior quarterly print, and BofA had already done the same in July. The Street's mean target sits near $29, against a current price of $21.75, implying apparent upside on paper. But the trend in targets is clearly downward, and the consensus rating factored alongside Benzinga's bear case tells a coherent story: Amentum's FY27 preliminary guidance flagged only 0% to 1% reported revenue growth, which undermined confidence in management's prior 4% to 6% long-term algorithm. The headwinds are specific, a roughly 3% NASA insourcing drag and a deliberate exit from low-margin work, but they are real. The bull case rests on a $48.2 billion backlog, a 1.1x book-to-bill, and improving net leverage (now 3.0x). BTIG, the most constructive voice remaining, kept its Buy rating with a $30 target after the August cut. The analyst recommendation differential factor scores in the 96th percentile, an unusually high reading that reflects how far the stock has fallen below the average target rather than broad analyst enthusiasm. Valuation is genuinely modest: EV/EBITDA at 7.5x and a P/E of 7.5x leave room for re-rating if the growth concerns prove manageable.
The ownership structure at Amentum deserves a mention. The activist register carries 13D filings, making it worth flagging. Alan E. Goldberg and ASP Amentum Investco LP each filed Schedule 13D disclosures around the time of the company's IPO with an 18% stake. Those were the founding private equity sponsors (Lindsay Goldberg and American Securities each hold around 18.4% on the institutional register) rather than activist disruptors in the traditional sense. Invesco has been the more active recent mover, growing its position to roughly 10.1% as last disclosed in May, up from 9.1% previously, and its reported Q3 holdings show further incremental buying. Stakes are as-last-disclosed around the 5% threshold, and a holder can fall below 5% without filing again. Dimensional Fund Advisors added roughly 1.75 million shares through Q3, making it another fund quietly accumulating while the stock traded below consensus targets.
The earnings history adds a layer of caution to all of the above. The last quarterly print on August 11 produced a one-day move of minus 7.9% and a five-day move of minus 14.3%. That reaction came despite adjusted EPS of $0.67 and segment profitability beating expectations, as the soft FY27 revenue framework dominated the response. Peers had a strong week: KBR, BAH, and SAIC all gained 9% to 11%, roughly in line with Amentum's own 9.5% weekly move, suggesting the rally is sector-wide rather than company-specific. Parsons led the group at 13.6%.
With 27 days to the November 24 report, the question is whether the call-side optimism in the options market reflects genuine expectations of a recovery in the growth outlook, or simply a trade on sector momentum that has lifted the whole defense services cohort this week. Wikipedia and ORTEX page views for Amentum hit an unusually high attention spike, with a z-score of 4.2 against the company's own 90-day history, a signal of retail interest rather than revenue direction. Watch whether short sellers continue to add through earnings or begin to cover as the print approaches.
Stocks in this article
See the live data behind this article on ORTEX.
Open AMTM on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 21:03
- Data as of
- 28 Oct 2026, 21:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.